International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Cervical, ovarian, endometrial, vaginal, vulvar, breast, testicular, penile, and prostate cancers belong to a family of malignancies called reproductive cancers. These malignancies occur in the reproductive organs. Despite significant progress in tumor therapy over the past few decades, the development of chemoresistance and metastatic disease is still the most common cause of death in patients with reproductive cancer. Thus, it is necessary the development of new therapeutic approaches that can improve the diagnosis and treatment of these patients. A better understanding of the molecular changes in reproductive cancers should lead to the identification of useful molecular biomarkers that can accurately predict tumor outcome and the development of chemoresistance and metastasis. Moreover, understanding the molecular mechanisms underlying these types of tumors may facilitate the development of new therapies based on specific targets, significantly improving the efficacy of the therapy itself.